CVS Health (CVS) Gets a Hold Rating from Robert W. Baird

Robert W. Baird analyst Eric Coldwell maintained a Hold rating on CVS Health (CVS) today and set a price target of $73.00. The company’s shares closed last Monday at $73.75, close to its 52-week high of $77.03.

According to, Coldwell is a 4-star analyst with an average return of 7.5% and a 57.4% success rate. Coldwell covers the Services sector, focusing on stocks such as Charles River Labs, AmerisourceBergen, and Quest Diagnostics.

Currently, the analyst consensus on CVS Health is a Strong Buy with an average price target of $86.89, which is a 16.3% upside from current levels. In a report released yesterday, Oppenheimer also assigned a Hold rating to the stock.

See today’s analyst top recommended stocks >>

CVS Health’s market cap is currently $95.95B and has a P/E ratio of 14.48. The company has a Price to Book ratio of 1.53.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts